Uncovering a key to the process of metastasis in human cancers: A review of critical regulators of anoikis

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 11, 2013, Pages 1795-1805

  Tan, Kevin ^a   Goldstein, David ^a   Crowe, Philip ^a   Yang, Jia Lin ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anoikis; Apoptosis; Cancer; Mechanism; Metastasis; Regulation

Indexed keywords

BH3 PROTEIN; CASPASE; CASPASE 8; CAVEOLIN 1; CYTOCHROME C; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROCASPASE 8; PROTEIN 14 3 3; PROTEIN 14 3 3 LAMBDA; PROTEIN BCL XL; PROTEIN BIT1; PROTEIN CDCP 1; PROTEIN KINASE B; PROTEIN MCL 1; PROTEIN P53; REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANOIKIS; APOPTOSIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOGENESIS; CELL SURVIVAL; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; LYMPH; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; ANIMAL; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANOIKIS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84892679861     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1482-5     Document Type: Review

References (94)

1. Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26(9):1324-1337. doi:10. 1038/sj.onc.1210220
2. Akiyama T, Dass CR, Choong PFM (2009) Bim-targeted cancer therapy: a link between drug action and underlying molecular changes. Mol Cancer Ther 8(12):3173-3180. doi:10.1158/1535-7163.MCT-09-0685
3. Alfano D, Iaccarino I, Stoppelli MP (2006) Urokinase signaling through its receptor protects against anoikis by increasing BCLxL expression levels. J Biol Chem 281(26):17758-17767
4. Bagnoli M, Canevari S, Mezzanzanica D (2010) Cellular FLICEinhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer. Int J Biochem Cell Biol 42(2):210-213. doi:10.1016/j. biocel.2009.11.015
5. Beagle B, Johnson GV (2010) AES/GRG5: more than just a dominant-negative TLE/GRG family member. Dev Dyn 239(11):2795-2805. doi:10.1002/dvdy.22439
6. Biliran H, Jan Y, Chen R, Pasquale EB, Ruoslahti E (2008) Protein kinase D is a positive regulator of Bit1 apoptotic function. J Biol Chem 283(42):28029-28037. doi:10.1074/jbc.M803139200
7. Boisvert-Adamo K, Longmate W, Abel EV, Aplin AE (2009) Mcl-1 is required for melanoma cell resistance to anoikis. Mol Cancer Res 7(4):549-556. doi:10.1158/1541-7786.MCR-08-0358
8. Bridges D, Moorhead GB (2005) 14-3-3 proteins: a number of functions for a numbered protein. Science's STKE (electronic resource): signal transduction knowledge environment (296)
9. Brunquell C, Biliran H, Jennings S, Ireland SK, Chen R, Ruoslahti E (2012) TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. Mol Cancer Res 10(11):1482-1495. doi:10.1158/1541-7786.MCR-12-0144
10. Chaabane W, User SD, El-Gazzah M, Jaksik R, Sajjadi E, Rzeszowska-Wolny J, Łos MJ (2013) Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Arch Immunol Ther Exp 61(1):43-58
11. Chen HX, Liu YJ, Zhou XD, Luo RY (2005) Expression of cellular FLICE/caspase-8 inhibitory protein is associated with malignant potential in endometrial carcinoma. Int J Gynecol Cancer 15(4):663-670
12. Chen LC, Chung IC, Hsueh C, Tsang NM, Chi LM, Liang Y, Chen CC, Wang LJ, Chang YS (2010) The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients. Cell Death Differ 17(9):1463-1473
13. Chen C, Zhou H, Wei F, Jiang L, Liu X, Liu Z, Ma Q (2011) Increased levels of hypoxia-inducible factor-1a are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma. J Orthop Res 29(1):143-151
14. Chen R, Braun GB, Luo X, Sugahara KN, Teesalu T, Ruoslahti E (2013) Application of a proapoptotic peptide to intratumorally spreading cancer therapy. Cancer Res 73(4):1352-1361. doi:10. 1158/0008-5472.CAN-12-1979
15. Chiarugi P, Giannoni E (2008) Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 76(11):1352-1364. doi:10.1016/j.bcp.2008.07.023
16. Chunhacha P, Pongrakhananon V, Rojanasakul Y, Chanvorachote P (2012) Caveolin-1 regulates Mcl-1 stability and anoikis in lung carcinoma cells. Am J Physiol Cell Physiol 302(9):C1284-C1292. doi:10.1152/ajpcell.00318.2011
17. Coates JM, Galante JM, Bold RJ (2010) Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res 164(2):301-308
18. Coll ML, Rosen K, Ladeda V, Filmus J (2002) Increased Bcl-xL expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cells. Oncogene 21(18):2908-2913
19. Daisy P, Saipriya K (2012) BCL-2 family proteins: the mitochondrial apoptotic key regulators. Curr Cancer Ther Rev 8(2):133-140
20. Danes CG, Wyszomierski SL, Lu J, Neal CL, Yang W, Yu D (2008) 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. Cancer Res 68(6):1760-1767. doi:10. 1158/0008-5472.CAN-07-3177
21. Danial NN (2007) BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 13(24):7254-7263. doi:10. 1158/1078-0432.CCR-07- 1598
22. Ekert PG, Vaux DL (2005) The mitochondrial death squad: hardened killers or innocent bystanders? Curr Opin Cell Biol 17(6):626-630. doi:10.1016/j.ceb. 2005.09.001
23. Fan YJ, Zong WX (2013) The cellular decision between apoptosis and autophagy. Chin J Cancer 32(3):121-129
24. Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H, Shen J, Zhao RY, Caraway NP, Katz RL, Stass SA, Jiang F (2007) Up-regulation of 14-3-3f in lung cancer and its implication as prognostic and therapeutic target. Cancer Res 67(16):7901-7906
25. Fan Y, Zhang YL, Wu Y, Zhang W, Wang YH, Cheng ZM, Li H (2008) Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells. World J Gastroenterol 14(3):428-434
26. Fleischer B, Schulze-Bergkamen H, Schuchmann M, Weber A, Biesterfeld S, Müller M, Krammer PH, Galle PR (2006) Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int J Oncol 28(1):25-32
27. Frankel A, Rosen K, Filmus J, Kerbel RS (2001) Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L). Cancer Res 61(12):4837-4841
28. Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22(56 REV. ISS. 8):9030-9040
29. Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13(5):555-562. doi:10.1016/S0955-0674(00)00251-9
30. Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617-647
31. Gasperowicz M, Otto F (2005) Mammalian Groucho homologs: redundancy or specificity? J Cell Biochem 95(4):670-687. doi:10.1002/jcb.20476
32. Geiger TR, Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta Rev Cancer 1796(2):293-308
33. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281(5381):1309-1312
34. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674
35. Hermeking H, Benzinger A (2006) 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol 16(3):183-192. doi:10.1016/j. semcancer.2006.03.002
36. Jan Y, Matter M, Pai JT, Chen YL, Pilch J, Komatsu M, Ong E, Fukuda M, Ruoslahti E (2004) A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell 116(5):751-762. doi:10.1016/S0092-8674(04)00204-1
37. Jenning S, Pham T, Ireland SK, Ruoslahti E, Biliran H (2013) Bit1 in anoikis resistance and tumor metastasis. Cancer Lett. doi:10. 1016/j.canlet.2013.01.043
38. Jensen K, Patel A, Klubo-Gwiezdzinska J, Bauer A, Vasko V (2011) Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis. Endocr Relat Cancer 18(5):613-626
39. Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4(2):139-163
40. Jin-Song Y, Zhao-Xia W, Cheng-Yu L, Xiao-Di L, Ming S, Yuan-Yuan G, Wei D (2011) Prognostic significance of Bcl-xL gene expression in human colorectal cancer. Acta Histochem 113(8):810-814
41. Kairouz-Wahbe R, Biliran H, Luo X, Khor I, Wankell M, Besch-Williford C, Pascual J, Oshima R, Ruoslahti E (2008) Anoikis effector Bit1 negatively regulates Erk activity. Proc Natl Acad Sci USA 105(5):1528-1532. doi:10.1073/pnas.0711357105
42. Kanayama S, Yamada Y, Kawaguchi R, Tsuji Y, Haruta S, Kobayashi H (2008) Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells. Oncol Rep 19(1):117-122
43. Karmali PP, Brunquell C, Tram H, Ireland SK, Ruoslahti E, Biliran H (2011) Metastasis of tumor cells is enhanced by downregulation of Bit1. PLoS One 6(8):e23840. doi:10.1371/journal.pone. 0023840
44. Kim YN, Koo KH, Sung JY, Yun UJ, Kim H (2012) Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol 2012. Article ID 306879. doi:10.1155/2012/306879
45. Li Z, Zhao J, Du Y, Park HR, Sun SY, Bernal-Mizrachi L, Aitken A, Khuri FR, Fu H (2008) Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci USA 105(1):162-167
46. Liu K, Liu F, Zhang N, Liu S, Jiang Y (2012) Pokemon silencing leads to bim-mediated anoikis of human hepatoma cell QGY7703. Int J Mol Sci 13(5):5818-5831. doi:10.3390/ ijms13055818
47. Lovell JF, Billen LP, Bindner S, Shamas-Din A, Fradin C, Leber B, Andrews DW (2008) Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by bax. Cell 135(6):1074-1084. doi:10.1016/j.cell.2008. 11.010
48. Matta A, Michael Siu KW, Ralhan R (2012) 14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Targets 16(5):515-523
49. Mawji IA, Simpson CD, Hurren R, Gronda M, Williams MA, Filmus J, Jonkman J, Da Costa RS, Wilson BC, Thomas MP, Reed JC, Glinsky GV, Schimmer AD (2007) Critical role for fasassociated death domain-like interleukin-1-converting enzymelike inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst 99(10):811-822
50. Michels J, Johnson PWM, Packham G (2005) Mcl-1. Int J Biochem Cell Biol 37(2):267-271. doi:10.1016/j.biocel.2004.04.007
51. Neal CL, Yu D (2010) 14-3-3f as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets 14(12):1343-1354. doi:10.1517/14728222.2010.531011
52. Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, Lu J, Danes CG, Guo H, Lan KH, Ensor J, Hittelman W, Hung MC, Yu D (2009) 14-3-3f overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res 69(8):3425-3432. doi:10.1158/0008-5472.CAN-08-2765
53. Nelson CM, Bissell MJ (2006) Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22:287-309
54. Ng YK, Wong EYL, Lau CPY, Chan JPL, Wong SCC, Chan ASK, Kwan MPC, Tsao SW, Tsang CM, Lai PBS, Chan ATC, Lui VWY (2012) K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr Virus (EBV)-associated nasopharyngeal carcinoma cells. Invest New Drugs 30(1):48-58
55. Obsil T, Obsilova V (2011) Structural basis of 14-3-3 protein functions. Semin Cell Dev Biol 22(7):663-672. doi:10.1016/j. semcdb.2011.09.001
56. Ott M, Norberg E, Zhivotovsky B, Orrenius S (2009) Mitochondrial targeting of tBid/Bax: a role for the TOM complex? Cell Death Differ 16(8):1075-1082
57. Pepper C, Lin TT, Pratt G, Hewamana S, Brennan P, Hiller L, Hills R, Ward R, Starczynski J, Austen B, Hooper L, Stankovic T, Fegan C (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood 112(9):3807-3817
58. Rao-Bindal K, Rao CK, Yu L, Kleinerman ES (2013) Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts. Pediatr Blood Cancer 60(4):575-579
59. Ravid D, Maor S, Werner H, Liscovitch M (2006) Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Adv Enzyme Regul 46:163-175
60. Roucou X, Montessuit S, Antonsson B, Martinou JC (2002) Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J 368(3):915-921. doi:10.1042/BJ20020972
61. Safa AR, Pollok KE (2011) Targeting the anti-apoptotic protein c-FLIP for cancer therapy. Cancers 3(2):1639-1671. doi:10. 3390/cancers3021639
62. Sáinz-Jaspeado M, Martin-Liberal J, Lagares-Tena L, Mateo-Lozano S, del Muro XG, Tirado OM (2011) Caveolin-1 in sarcomas: friend or foe? Oncotarget 2(4):305-312
63. Sakamoto S, Kyprianou N (2010) Targeting anoikis resistance in prostate cancer metastasis. Mol Aspects Med 31(2):205-214
64. Sakuma Y, Tsunezumi J, Nakamura Y, Yoshihara M, Matsukuma S, Koizume S, Miyagi Y (2011) ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis. Oncol Rep 25(3):661-667. doi:10. 3892/or.2010.1123
65. Sayers TJ (2011) Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol Immunother 60(8):1173-1180
66. Seo SW, Lee H, Lee HI, Kim HS (2011) The role of TLE1 in synovial sarcoma. J Orthop Res 29(7):1131-1136. doi:10.1002/jor.21318
67. Shigemasa K, Katoh O, Shiroyama Y, Mihara S, Mukai K, Nagai N, Ohama K (2002) Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J Cancer Res 93(5):542-550
68. Shirane M, Nakayama KI (2003) Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5(1):28-37. doi:10.1038/ncb894
69. Simpson CD, Anyiwe K, Schimmer AD (2008) Anoikis resistance and tumor metastasis. Cancer Lett 272(2):177-185. doi:10.1016/ j.canlet.2008.05.029
70. Soltani-Arabshahi R, Leboeuf C, Rivet J, Pisonero H, Zhao WL, Bachelez H, Ameisen JC, Janin A (2009) Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL. J Investig Dermatol 129(7):1703-1709
71. Stupack DG, Cheresh DA (2004) A Bit-role for integrins in apoptosis. Nat Cell Biol 6(5):388-389. doi:10.1038/ncb0504-388
72. Taddei ML, Giannoni E, Fiaschi T, Chiarugi P (2012) Anoikis: an emerging hallmark in health and diseases. J Pathol 226(2):380-393. doi:10.1002/path.3000
73. Tan MJ, Teo Z, Sng MK, Zhu P, Tan NS (2012) Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res 10(6):677-688. doi:10.1158/1541-7786.MCR-11-0519
74. Tang MKS, Zhou HY, Yam JWP, Wong AST (2010) c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia 12(2):128-138
75. Touzeau C, Dousset C, Bodet L, Gomez-Bougie P, Bonnaud S, Moreau A, Moreau P, Pellat-Deceunynk C, Amiot M, Le Gouill S (2011) ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2 high/Mcl-1 low profile and synergizes with other antineoplastic agents. Clin Cancer Res 17(18):5973-5981
76. Uekita T, Sakai R (2011) Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci 102(11):1943-1948. doi:10.1111/j.1349-7006.2011.02052.x
77. Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T, Sakai R (2007) CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol 27(21):7649-7660
78. Ullenhag GJ, Mukherjee A, Watson NFS, Al-Attar AH, Scholefield JH, Durrant LG (2007) Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients. Clin Cancer Res 13(17):5070-5075
79. Ulukaya E, Acilan C, Yilmaz Y (2011) Apoptosis: why and how does it occur in biology? Cell Biochem Funct 29(6):468-480
80. Valnet-Rabier MB, Challier B, Thiebault S, Angonin R, Margueritte G, Mougin C, Kantelip B, Deconinck E, Cahn JY, Fest T (2005) c-FLIP protein expression in Burkitt's lymphomas is associated with a poor clinical outcome. Br J Haematol 128(6):767-773
81. Van Mau N, Kajava AV, Bonfils C, Martinou JC, Harricane MC (2005) Interactions of Bax and tBid with lipid monolayers. J Membr Biol 207(1):1-9. doi:10.1007/s00232-005-0799-7
82. Wang L, Liu Q, Zhou W, Shao H, Li F, Li X (2009) Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer. J Surg Oncol 100(5):396-400
83. Wang ZX, Yang JS, Pan X, Wang JR, Li J, Yin YM, De W (2010) Functional and biological analysis of Bcl-xL expression in human osteosarcoma. Bone 47(2):445-454
84. Watanabe J, Kushihata F, Honda K, Sugita A, Tateishi N, Mominoki K, Matsuda S, Kobayashi N (2004) Prognostic significance of Bcl-xL in human hepatocellular carcinoma. Surgery 135(6):604-612
85. Wong WWL, Puthalakath H (2008) Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life 60(6):390-397. doi:10.1002/iub.51
86. Woods NT, Yamaguchi H, Lee FY, Bhalla KN, Wang HG (2007) Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Res 67(22):10744-10752
87. Yang D, Wang S, Brooks C, Dong Z, Schoenlein PV, Kumar V, Ouyang X, Xiong H, Lahat G, Hayes-Jordan A, Lazar A, Pollock R, Lev D, Liu K (2009) IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Res 69(3):1080-1088. doi:10.1158/0008-5472.can-08-2520
88. Yang X, Cao W, Zhou J, Zhang W, Zhang X, Lin W, Fei Z, Lin H, Wang B (2011) 14-3-3Zeta positive expression is associated with a poor prognosis in patients with glioblastoma. Neurosurgery 68(4):932-938
89. Yu X, Liu L, Cai B, He Y, Wan X (2008) Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci 29(3):543-552
90. Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D, Wang CY (2002) Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFjB. J Biol Chem 277(28):25203-25208. doi:10.1074/jbc.M201598200
91. Zhan M, Zhao H, Han ZC (2004) Signalling mechanisms of anoikis. Histol Histopathol 19(3):973-983
92. Zhang BY, Yuan F, Xiao JC, Liu BY, Jin XL (2010) Significance of expression of 14-3-3f protein in gastric cancer. J Shanghai Jiaotong Univ (Med Sci) 30(9):1129-1132
93. Zhang T, Zhao C, Luo L, Zhao H, Cheng J, Xu F (2012) The expression of Mcl-1 in human cervical cancer and its clinical significance. Med Oncol 29(3):1985-1991
94. Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, Pal M, Lam CR, Boukamp P, Pan JY, Tan SH, Kersten S, Li HY, Ding JL, Tan NS (2011) Angiopoietin-like 4 protein elevates the prosurvival intracellular O2-: H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19(3):401-415